SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-24-003575
Filing Date
2024-05-16
Accepted
2024-05-16 15:46:34
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DECEMBER 2023 cannapharmarx_i10k-123123.htm   iXBRL 10-K 1216805
2 CERTIFICATION cannapharmarx_ex3101.htm EX-31.1 11606
3 CERTIFICATION cannapharmarx_ex3102.htm EX-31.2 11723
4 CERTIFICATION cannapharmarx_ex3200.htm EX-32 4774
10 GRAPHIC image_001.jpg GRAPHIC 3352
11 GRAPHIC image_002.jpg GRAPHIC 3483
  Complete submission text file 0001683168-24-003575.txt   5589159

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20231231.xsd EX-101.SCH 53725
6 XBRL CALCULATION FILE cpmd-20231231_cal.xml EX-101.CAL 65161
7 XBRL DEFINITION FILE cpmd-20231231_def.xml EX-101.DEF 167343
8 XBRL LABEL FILE cpmd-20231231_lab.xml EX-101.LAB 365266
9 XBRL PRESENTATION FILE cpmd-20231231_pre.xml EX-101.PRE 313045
86 EXTRACTED XBRL INSTANCE DOCUMENT cannapharmarx_i10k-123123_htm.xml XML 653015
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27055 | Film No.: 24955247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)